 |
 |
 |
 |
|
Intellectual Property Strategies in Developing Therapeutic Small Molecules and AntibodiesJie Zhou, PhD, JD, Morrison & Foerster LLP. Chinese Bioscience Association (CBA) invites you for a seminar on IP strategies for small molecule and antibody products. Dr. Jie Zhou of Morrison & Foerster will share her experience as a legal counsel to many biotech companies in developing strategies to maximize the values of their R&D programs. Please join us for an informative presentation and an opportunity to meet with colleagues in the field. In addition, this is a great opportunity to visit Dowler-Gruman Architechs who specializes in the designs of office buildings and manufacturing facilities for many local biotech companies. Dr. Jie Zhou is an intellectual property law attorney specializing on patent law in the Palo Alto office of Morrison & Foerster. She primarily represents clients in the areas of biotechnology and pharmaceuticals in their world-wide patent portfolio development, including the procurement, management, and strategic planning. Besides patent prosecution, her practice includes the preparation of opinions (patentability, freedom-to-operate, and invalidity); due diligence reviews for financings, collaborations and/or partnering deals; and mining clients' portfolios for opportunities to maximize value. Dr. Zhou is a member of the State Bar of California and is admitted to practice before the United States Patent & Trademark Office. Dr. Zhou holds a Ph.D. in Molecular Biology and Biochemistry from University of California, Davis, an M.A. in Biology from Beijing University, China, and a J.D. from University of San Francisco.
Send Questions, and Comments to Webmaster/Database,
info@cbasf.org © 2006-2008 by Chinese Bioscience Association. All Rights Reserved. 
|
||
 |
 |
 |
 |
 |
 |
 |
